ACTU — ACTUATE THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ACTU?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their ACTU position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +1 tracked investor added or increased positions last quarter (Izzy Englander)
- +1 tracked investors reported holding ACTU at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About ACTUATE THERAPEUTICS INC (ACTU)
ACTUATE THERAPEUTICS INC (ACTU) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $147,927. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ACTU
How many top investors track ACTU
Only 1 tracked investor report this position.
ACTU Ownership Composition
How ACTUATE THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ACTU
1 tracked investor has since exited this position — listed separately below.
- Izzy EnglanderJun 30, 2026Millennium ManagementShares96.7KValue$147.9K% Portfolio0.00%
Previously held ACTU
These investors reported ACTU in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | 14.2K | $96K | Mar 31, 2025 |
Recent activity
- $82.5KMay 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
- $147.9KAug 14, 2026
- New$96KMay 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
Frequently asked questions
- How many institutional investors hold ACTU?
- 1 tracked institutional investor disclosed a position in ACTU (ACTUATE THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ACTU?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ACTU, valued at $147,927.
- Did institutional ownership of ACTU increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 0 reduced, and 2 fully exited ACTU.
- Where does this ACTU ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.